|

Blood And Tears in Alzheimer's Disease

RECRUITINGSponsored by Danish Dementia Research Centre
Actively Recruiting
SponsorDanish Dementia Research Centre
Started2024-03-18
Est. completion2026-01-31
Eligibility
Age30 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06567431

Summary

This study aims to investigate whether biomarkers of Alzheimer's disease can be found in tearfluid, as well as dried bloodspots in patients with Alzheimer's disease, other dementia diagnoses compared to controls.

Eligibility

Age: 30 Years+Healthy volunteers accepted
Inclusion Criteria:

Inclusion criteria for patients:

* Lumbar puncture with CSF avaiable for analysis
* Diagnosis of Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), vascular dementia (VaD) or Normal pressure hydrocephalus (NPH)
* Of legal age.

Inclusion criteria for controls:

* Lumbar puncture with CSF avaiable for analysis
* No neurological disease.
* Of legal age.

Exclusion Criteria:

* No lumbar puncture
* Clinically assessed as unfit to participate in the project.

Conditions2

Alzheimer's DiseaseNeurodegenerative Diseases

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.